Posted: January 18, 2018
On Tuesday, January 16th CSRO staff joined allies in Albany, New York to educate lawmakers on utilization management, and pending legislation that promises to improve patient access and continuity of care. Representatives of CSRO, the New York State Rheumatology Society, Lupus and Allied Diseases Association, Global Healthy Living Foundation, and the U.S. Pain Foundation conducted 15 meetings with key New York state legislators to help solidify momentum behind A2317 and S5022.
Both of these pieces of legislation would implement important patient protections by prohibiting insurers from moving their prescription drugs to more restrictive tiers of their formularies, or removing them altogether, within a plan year. This bait and switch experienced by patients, who may sign up for a health plan primarily because of a specific medication’s availability, disrupts continuity of care with the potential for irreversible effects on disease progression.
Please view our photo gallery documenting the day’s proceedings:
